Clarus Therapeutics reports $1.41 million net loss for December

By Sarah Lizee

Olympia, Wash., Jan. 24 – Clarus Therapeutics Holdings, Inc. debtor Clarus Therapeutics, Inc. reported a $1.41 million net loss on zero gross income/sales for December, according to its monthly operating report filed Monday with the U.S. Bankruptcy Court for the District of Delaware.

In comparison, the company reported an $832,376 net loss on zero gross income/sales for November.

The cash balance at the end of December was $3.84 million, down from $6.15 million at the end of November.

The Northbrook, Ill.-based pharmaceutical company filed bankruptcy under Chapter 11 on Sept. 5. The case number is 22-10845.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.